Overview

Report Segment | Healthcare | Report ID – HGRI8954

---

E-clinical Solution Market Overview:

The market for E-clinical Solution was valued at >9.4 Bn USD in the year 2023 and expected to grow at a CAGR of >14.3% during the period 2024  -2030.

E-clinical solutions are software programs or suites of programs that help healthcare organizations manage clinical data and processes electronically. Many tasks can be automated and streamlined using e-clinical solutions, including patient scheduling, registration, clinical data capture and management, order entry, medication management, result reporting, billing, collections, and quality management. Healthcare organizations can benefit from e-clinical solutions in several ways, such as increased productivity and efficiency, reduced costs, improved accuracy and quality of care, enhanced patient satisfaction, and better communication and collaboration.

One of the key drivers of market growth is the increased R&D efforts by biopharma and pharmaceutical companies. Additionally, the growing adoption of software solutions in clinical trials is expected to further fuel the market. The COVID-19 pandemic has also accelerated market adoption, as organizations invested in enhanced healthcare IT solutions to help combat the crisis.

Market Dynamics

E-clinical Solution Market Growth Indicators:

• Increase in number of clinical trials: The need for clinical trials is being driven by the rising incidence of chronic illnesses as well as the creation of novel medications and treatments.The clinical trial process can be streamlined and optimised with e-clinical solutions, which will make it quicker, more effective, and less expensive.
• Collaboration and partnership: To drive innovation and establish comprehensive e-clinical solutions, collaboration between pharmaceutical companies, CROs, technology suppliers, and healthcare institutions will be essential.Through these collaborations, clinical trials will be conducted more quickly and effectively, which will speed up the development of novel therapies and their distribution to patients.
• Surge in demand for cloud based solutions: Cloud-based e-clinical solutions offer scalability, affordability, and accessibility, making them attractive for smaller organisations and research institutions.This shift towards cloud-based solutions is expected to fuel market growth in the near future.
• Wearable devices and sensors: Real-time patient data collection via wearable technology and sensors is becoming more common, offering important insights on the state of patients’ health and the course of diseases.The accuracy and effectiveness of clinical studies will be enhanced by the integration of these devices with e-clinical solutions, which will provide comprehensive patient monitoring.
• Rise of data analytics and AI: Large volumes of data are produced by e-clinical systems, which supports the application of artificial intelligence (AI) and advanced analytics. AI systems facilitate the identification of patterns, forecast patient outcomes, customise treatment regimens, and enhance clinical trial designs, all of which contribute to more productive and successful research.
• Decentralised clinical trial (DCTs): DCTs use technology to conduct clinical trials across a variety of geographical areas, which lowers patient burden and speeds up patient enrollment. This trend encourages people living in underserved areas to have access to clinical trials, which will increase the diversity and inclusivity of the research population.

Market Segments

E-clinical Solution Market Report Segments Overview:

Product Segment Overview:

In 2023, the CTMS segment held the highest revenue share and dominated the market. Due to high-quality clinical data becoming more and more important, ECOA is predicted to increase at the quickest rate during the projected period. A growing number of measures of patient-reported, clinician-reported, and observer-reported outcomes are using ECOA to help preserve overall quality. Using eCOA systems for data capture enhances the quality of information captured, expedites data collecting processes, and provides efficient data analysis.

Delivery Mode Segment  Overview:

The market is controlled by the web and cloud-based segments. The segment’s prominence can be ascribed to related advantages such ease of use, accessibility, and less investment needs. Because web and cloud-based solutions are so easily customisable, suppliers can alter how information is presented for various user groups. These products also have a higher degree of interoperability. Over the course of the projection period, the segment is expected to hold its current position.

Clinical Phase Segment Overview:

The market was led by the Phase III category in the historical period (2019 -2022). The market is expanding as a result of the increasing necessity to include clinical data management software in order to reduce overall costs and boost process effectiveness. An important driver of the segment’s growth is the rising number of medications that are making it to phase III. Phase III studies a drug’s effectiveness with a patient population larger than 1,000. The number of patients included in the study increases its complexity, which in turn drives up the need for computer-based systems for data administration and accelerates the use of eClinical solutions.

End user Segment Overview:

The market is dominated by the CROs category in the historical period (2019 -2022).. The market’s potential for expansion is being further expanded by the growing use of eClinical solutions in research. The advantages of using CROs for clinical trial outsourcing account for the increased growth in this market. These advantages include lower costs, better service efficiency, more productivity, and a stronger emphasis on core development areas that are essential to a business’ expansion.

Regional Outlook

E-clinical Solution Market Regional Outlook:

North America: 

The North America region accounts for the largest market share in the region. Leading providers of eClinical solutions, including Oracle Corporation, Medidata Solutions, and Parexel International Corporation, are based in the region. The largest eClinical market in North America is found in the United States. Although they are smaller markets, Mexico and Canada have great development potential. Growth in the North American market is being driven by factors like a robust pharmaceutical sector, a sizable patient pool, and a supportive regulatory environment. 

Asia Pacific: 

In Asia Pacific, the market for eClinical solutions is anticipated to grow rapidly over the forecast period. The region’s need for software solutions is being driven by a high rate of unmet medical demands as well as an increase in the prevalence of key chronic diseases such cancer, cardiovascular disease, and infectious diseases. Because of their vast patient populations and low costs, China, India, Korea, and Japan are seeing an increase in the number of studies that are outsourced to them. Thus, the usage of eClinical solutions in these regions has increased as a result of this outsourcing. Government funding for drug development and research is a major factor driving the growth of the APAC market, which is expected to continue to rise over the projected period despite being an emerging economy.

Europe: 

In the upcoming years, the European eClinical solutions market is anticipated to rise significantly due to a number of important aspects. Germany, France and Uk are the dominators of this market. Increasing number of ageing populations, the prevalence of chronic illnesses rises, necessitating more effective and economical clinical trials.The need for eClinical solutions is being driven by significant investments made in this area by pharmaceutical corporations and European governments. To encourage the use of eClinical solutions, the European Union has put in place a number of initiatives and rules, such as the Clinical Trials Regulation (CTR). EClinical systems are becoming even more capable with the integration of new technologies like blockchain, AI, and ML.

Middle East & Africa: 

Even though the eClinical market is expanding significantly worldwide, the Middle East and Africa (MEA) area is still a minor participant at this time. Saudi Arabia is the market dominator for this region. But due to a number of causes, it is anticipated to grow at one of the fastest rates in the upcoming years. The MEA region’s governments are making significant investments in healthcare technology and infrastructure, which is fostering a climate that is conducive to the use of eClinical solutions. The MEA region’s biotechnology and pharmaceutical sectors are expanding quickly, which is driving up demand for eClinical solutions and clinical trials. Researchers and medical professionals in the MEA area are becoming more aware of the advantages of eClinical solutions.

Key Players

E-clinical Solution Market Players Mapping:

• Datatrak International, Inc.
• Oracle Corporation
• Parexel International Corporation
• Veeva Systems
• Mednet Solutions
• Saama Technologies, Inc
• Dassault Systemes
• Bioclinica
• CRF Health
• ERT Clinical
• eclinical works
• IBM Watson Health
• eclinical Solutions
• Signant Health
• 4G Clinical
• Maxis IT
• Medrio Inc
• Clinipace
• Aris Global

In October 2023, Medidata Solutions, a cloud-based platform for life sciences R&D, and IQVIA, a top global provider of advanced analytics, technological solutions, and contract research services to the life sciences industry, announced their merger. Combining Medidata’s industry-leading clinical trial platform with IQVIA’s data and analytics skills makes this combination a powerhouse in the eClinical solutions market.In May 2023, The Elluminate IQ solution from eClinical Solutions LLC expanded its machine learning (ML) and artificial intelligence (AI) capabilities. These state-of-the-art ML/AL capabilities can help data management teams do data evaluations more effectively and scalable.

Report Coverage

E-clinical Solution Market Coverage:

By Product type:

• Clinical Trial Management Systems (CTMS)
• Clinical Data Management Systems (CDMS)
• Electronic Data Capture (EDC)
• Randomization and Trial Supply Management (RTSM)
• Electronic Clinical Outcome Assessments (eCOA)
• Safety Solutions
• Electronic Trial Master File (eTMF) Systems
• Electronic Consent Solutions
• Regulatory Information Management Systems (RIMS) 
• Clinical Analytics Platforms

By Delivery mode type:

• Web based
• Cloud based
• Licensed Enterprise

By Clinical Phase type:

• Phase I
• Phase II
• Phase III
• Phase IV

By End User  type:

• Pharmaceutical companies
• Biopharmaceutical companies
• Consulting Service companies
• Contract Research Organization (CRO)
• Hospitals and Healthcare organisations
• Medical Devices companies
• Academic institutions

By Region:

• North America
  • US
  • Canada
  • Mexico
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of APAC
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of MEA

E-clinical Solution Market Report Outlook

E-clinical Solution Market Coverage	2019- 2030
Fastest Growing Region	North America
E-clinical Solution Market Forecast	2024 – 2030
Historical Data	2019 – 2022
Base Year	2023
Competition Benchmarking	10 + Key Players Mapping
Report Format	PPT + PDF + Excel